KAKKIS EMIL D - Insider Transactions
Insider Type
individual
Companies
1
Average
1,246,119
Total Txns
8
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 1 | -1 | 0.00 | 1,436,100.00 | -1,436,100.00 |
| 2024 | 0 | 5 | -5 | 0.00 | 4,379,281.21 | -4,379,281.21 |
| 2025 | 0 | 2 | -2 | 0.00 | 4,153,571.40 | -4,153,571.40 |
| Total: | 0 | 8 | 8 | 0.00 | 9,968,952.61 | -9,968,952.61 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
42.10 USD |
73,434 Sold |
3,091,571 USD |
28/02/2025 | 03/03/2025 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
42.48 USD |
25,000 Sold |
1,062,000 USD |
28/02/2025 | 28/02/2025 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
42.23 USD |
11,727 Sold |
495,231 USD |
30/12/2024 | 30/12/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
50.00 USD |
8,273 Sold |
413,650 USD |
09/12/2024 | 10/12/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
55.85 USD |
20,000 Sold |
1,117,000 USD |
03/09/2024 | 03/09/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
50.17 USD |
20,000 Sold |
1,003,400 USD |
06/08/2024 | 06/08/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
45.00 USD |
30,000 Sold |
1,350,000 USD |
07/02/2024 | 07/02/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
47.87 USD |
30,000 Sold |
1,436,100 USD |
29/12/2023 | 29/12/2023 |